The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome

Diagnostic Microbiology and Infectious Disease

Volumn 59, Issue 3, 2007, Pages 235-242

  Orth, Dorothea ^a   Grif, Katharina ^a   Khan, Abdul B ^a   Naim, Asma ^a   Dierich, Manfred P ^a   Würzner, Reinhard ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Cytotoxicity; EHEC; Genotype; HUS; stx

Indexed keywords

SHIGA TOXIN;

ALLELE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; CYTOTOXICITY; ENTEROTOXIGENIC ESCHERICHIA COLI; ENZYME IMMUNOASSAY; GENOTYPE; HEMOLYTIC UREMIC SYNDROME; NONHUMAN; PATHOGENIC ESCHERICHIA COLI; PRIORITY JOURNAL; VERO CELL;

ADHESINS, BACTERIAL; ANIMALS; CERCOPITHECUS AETHIOPS; ESCHERICHIA COLI PROTEINS; FOOD MICROBIOLOGY; FOOD POISONING; GENOTYPE; HEMOLYTIC-UREMIC SYNDROME; HUMANS; IMMUNOENZYME TECHNIQUES; SHIGA TOXIN 1; SHIGA TOXIN 2; SHIGA-TOXIGENIC ESCHERICHIA COLI; VERO CELLS; VIRULENCE;

EID: 35548955176     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2007.04.013     Document Type: Article

References (49)

1. Aldick T., Bielaszewska M., Zhang W., Brockmeyer J., Schmidt H., Friedrich A.W., Kim K.S., Schmidt M.A., and Karch H. Hemolysin from Shiga toxin-negative Escherichia coli O26 strains injures microvascular endothelium. Microbes. Infect. 9 (2007) 282-290
2. Bielaszewska M., Zhang W., Tarr P.I., Sonntag A.K., and Karch H. Molecular profiling and phenotype analysis of Escherichia coli O26:H11 and O26:NM: secular and geographic consistency of enterohemorrhagic and enteropathogenic isolates. J. Clin. Microbiol. 43 (2005) 4225-4228
3. Bielaszewska M., Sinha B., Kuczius T., and Karch H. Cytolethal distending toxin from Shiga toxin-producing Escherichia coli O157 causes irreversible G2/M arrest, inhibition of proliferation, and death of human endothelial cells. Infect. Immun. 73 (2005) 552-562
4. Bielaszewska M., Friedrich A.W., Aldick T., Schurk-Bulgrin R., and Karch H. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clin. Infect. 43 (2006) 1160-1167
5. Bielaszewska M., Prager R., Zhang W., Friedrich A.W., Mellmann A., Tschape H., and Karch H. Chromosomal dynamism in progeny of outbreak-related sorbitol-fermenting enterohemorrhagic Escherichia coli O157:NM. Appl. Environ. Microbiol. 72 (2006) 1900-1909
6. Brooks J.T., Sowers E.G., Wells J.G., Greene K.D., Griffin P.M., Hoekstra R.M., and Strockbine N.A. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J. Infect. Dis. 192 (2005) 1422-1429
7. Calderwood S.B., Acheson D.W., Keusch G.T., Barrett T.J., Griffin P.M., Stockbine N.A., Swaminathan B., Kaper J.B., Levine M.M., Kaplan B.S., Karch H., O'Brien A.D., Obrig T.G., Takeda Y., Tarr P.I., and Wachsmuth I.K. Proposed new nomenclature for SLT (VT) family. ASM News 62 (1996) 118-119
8. De Baets L., Van der Taelen I., De Filette M., Pierard D., Allison L., De Greve H., Hernalsteens J.P., and Imberechts H. Genetic typing of Shiga toxin 2 variants of Escherichia coli by PCR-restriction fragment length polymorphism analysis. Appl. Environ. Microbiol. 70 (2004) 6309-6314
9. Eklund M., Scheutz F., and Siitonen A. Clinical isolates of non-O157 Shiga toxin-producing Escherichia coli: serotypes, virulence characteristics, and molecular profiles of strains of the same serotype. J. Clin. Microbiol. 39 (2001) 2829-2834
10. Eklund M., Leino K., and Siitonen A. Clinical Escherichia coli strains carrying stx genes: stx variants and stx-positive virulence profiles. J. Clin. Microbiol. 40 (2002) 4585-4593
11. Friedrich A.W., Bielaszewska M., Zhang W.L., Pulz M., Kuczius T., Ammon A., and Karch H. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J. Infect. Dis. 185 (2002) 74-84
12. Friedrich A.W., Borell J., Bielaszewska M., Fruth A., Tschape H., and Karch H. Shiga toxin 1c-producing Escherichia coli strains: phenotypic and genetic characterization and association with human disease. J. Clin. Microbiol. 41 (2003) 2448-2453
13. Gerber A., Karch H., Allerberger F., Verweyen H.M., and Zimmerhackl L.B. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J. Infect. Dis. 186 (2002) 493-500
14. Grif K., Dierich M.P., Karch H., and Allerberger F. Strain-specific differences in the amount of Shiga toxin released from enterohemorrhagic Escherichia coli O157 following exposure to subinhibitory concentrations of antimicrobial agents. Eur. J. Clin. Microbiol. Infect. Dis. 17 (1998) 761-766
15. Jackson M.P., Neil R.J., O'Brien A.D., Holmes R.K., and Newland J.W. Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin I and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933. FEMS Microbiol. Lett. 44 (1987) 109-114
16. Jelacic J.K., Damrow T., Chen G.S., Jelacic S., Bielaszewska M., Ciol M., Carvalho H.M., Melton-Celsa A.R., O'Brien A.D., and Tarr P.I. Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J. Infect. Dis. 188 (2003) 719-729
17. Johnson K.E., Thorpe C.M., and Sears C.L. The emerging clinical importance of non-O157 Shiga toxin-producing Escherichia coli. Clin. Infect. Dis. 43 (2006) 1587-1595
18. Karch H., Tarr P.I., and Bielaszewska M. Enterohaemorrhagic Escherichia coli in human medicine. Int. J. Med. Microbiol. 295 (2005) 405-418
19. Karmali M.A., Petric M., Lim C., Fleming P.C., Arbus G.S., and Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J. Infect. Dis. 151 (1985) 775-782
20. Kokai-Kun J.F., Melton-Celsa A.R., and O'Brien A.D. Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2d. J. Biol. Chem. 275 (2000) 3713-3721
21. Konowalchuk J., Speirs J.I., and Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect. Immun. 18 (1977) 775-779
22. Kuczius T., Bielaszewska M., Friedrich A.W., and Zhang W. A rapid method for the discrimination of genes encoding classical Shiga toxin (Stx) 1 and its variants, Stx1c and Stx1d, in Escherichia coli. Mol. Nutr. Food Res. 48 (2004) 515-521
23. Leung P.H., Peiris J.S., Ng W.W., Robins-Browne R.M., Bettelheim K.A., and Yam W.C. A newly discovered verotoxin variant, VT2g, produced by bovine verocytotoxigenic Escherichia coli. Appl. Environ. Microbiol. 69 (2003) 7549-7553
24. Lingwood C.A. Role of verotoxin receptors in pathogenesis. Trends Microbiol. 4 (1996) 147-153
25. Meisen I., Friedrich A.W., Karch H., Witting U., Peter-Katalinic J., and Müthing J. Application of combined high-performance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1. Rapid Commun. Mass Spectrom. 19 (2005) 3659-3665
26. Mellmann A., Bielaszewska M., Zimmerhackl L.B., Prager R., Harmsen D., Tschape H., and Karch H. Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. Clin. Infect. Dis. 41 (2005) 785-792
27. Melton-Celsa A.R., Darnell S.C., and O'Brien A.D. Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice. Infect. Immun. 64 (1996) 1569-1576
28. Misselwitz J., Karch H., Bielaszewska M., John U., Ringelmann F., Rönnefarth G., and Patzer L. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11. Pediatr. Infect. Dis. J. 22 (2003) 349-354
29. Muniesa M., De Simon M., Prats G., Ferrere D., Panella H., and Jofre J. Shiga toxin 2-converting bacteriophages associated with clonal variability in Escherichia coli O157:H7 strains of human origin isolated from a single outbreak. Infect. Immun. 71 (2003) 4554-4562
30. O'Brien A.D., Tesh V.L., Donohue Rolfe A., Jackson M.P., Olsnes S., Sandvig K., Lindberg A.A., and Keusch G.T. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr. Top. Microbiol. Immunol. 180 (1992) 65-94
31. Ørskov F., and Ørskov I. Serotyping of Escherichia coli. Meth. Microbiol. 14 (1984) 43-112
32. Orth D., Grif K., Dierich M.P., and Würzner R. Cytolethal distending toxins in Shiga toxin-producing Escherichia coli: alleles, serotype distribution and biological effects. J. Med. Microbiol. 55 (2006) 1487-1492
33. Orth D., Grif K., Dierich M.P., and Würzner R. Prevalence, structure and expression of urease genes in Shiga toxin-producing Escherichia coli from humans and the environment. Int. J. Hyg. Environ. Health 209 (2006) 513-520
34. Orth D., Grif K., Dierich M.P., and Würzner R. Variability in tellurite resistance and the ter gene cluster among Shiga toxin-producing Escherichia coli isolated from humans, animals and food. Res. Microbiol. 158 (2007) 105-111
35. 5 cytotoxins produced by Shiga toxigenic Escherichia coli. J. Exp. Med. 200 (2004) 35-46
36. Pierard D., Muyldermas G., Moriau L., Stevens D., and Lauwers S. Identification of a new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates. J. Clin. Microbiol. 36 (1998) 3317-3322
37. Prager R., Annemuller S., and Tschäpe H. Diversity of virulence patterns among Shiga toxin-producing Escherichia coli from human clinical cases-need for more detailed diagnostics. Int. J. Med. Microbiol. 295 (2005) 29-38
38. Schmidt H., Scheef J., Morabito S., Caprioli A., Wieler L., and Karch H. A new Shiga toxin variant (Stx2f) from Escherichia coli isolated from pigeons. Appl. Environ. Microbiol. 66 (2000) 1205-1208
39. - strain E32511. Infect. Immun. 59 (1991) 1065-1073
40. Sonntag A.K., Prager R., Bielaszewska M., Zhang W., Fruth A., Tschape H., and Karch H. Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany. J. Clin. Microbiol. 42 (2004) 954-962
41. Sonntag A.K., Bielaszewska M., Mellmann A., Dierksen N., Schierack P., Wieler L.H., Schmidt M.A., and Karch H. Shiga toxin 2e-producing Escherichia coli isolates from humans and pigs differ in their virulence profiles and interactions with intestinal epithelial cells. Appl. Environ. Microbiol. 71 (2005) 8855-8863
42. Sonntag A.K., Zenner E., Karch H., and Bielaszewska M. Pigeons as a possible reservoir of Shiga toxin 2f-producing Escherichia coli pathogenic to humans. Berl. Munch. Tierarztl. Wochenschr. 118 (2005) 464-470
43. Tarr P.I., Gordon C.A., and Chandler W.L. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365 (2005) 1073-1086
44. Wagner P.L., and Waldor M.K. Bacteriophage control of bacterial virulence. Infect. Immun. 70 (2002) 3985-3993
45. Weinstein D.L., Jackson M.P., Samuel J.E., Holmes R.K., and O'Brien A.D. Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine. J. Bacteriol. 170 (1988) 4223-4230
46. Werber D., Fruth A., Buchholz U., Prager R., Kramer M.H., Ammon A., and Tschape H. Strong association between Shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome. Eur. J. Clin. Microbiol. Infect. Dis. 22 (2003) 726-730
47. 1c in Escherichia coli strains isolated from humans. J. Clin. Microbiol. 40 (2002) 1441-1446
48. Zhang W., Bielaszewska M., Friedrich A.W., Kuczius T., and Karch H. Transcriptional analysis of genes encoding Shiga toxin 2 and its variants in Escherichia coli. Appl. Environ. Microbiol. 711 (2005) 558-561
49. Zhang W., Mellmann A., Sonntag A.K., Wieler L., Bielaszewska M., Tschape H., Karch H., and Friedrich A.W. Structural and functional differences between disease-associated genes of enterohaemorrhagic Escherichia coli O111. Int. J. Med. Microbiol. 297 (2006) 17-26